Barclays Begins Coverage on Aveanna Healthcare (NASDAQ:AVAH)

Barclays began coverage on shares of Aveanna Healthcare (NASDAQ:AVAH - Free Report) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm issued an equal weight rating and a $5.50 price target on the stock.

A number of other research analysts have also issued reports on AVAH. Wall Street Zen lowered shares of Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 27th. UBS Group boosted their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday, May 9th. Finally, Truist Financial lowered their target price on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, Aveanna Healthcare presently has an average rating of "Hold" and an average price target of $5.20.

Aveanna Healthcare Price Performance

Shares of NASDAQ AVAH traded up $0.17 during mid-day trading on Wednesday, hitting $4.63. The company had a trading volume of 480,689 shares, compared to its average volume of 342,245. Aveanna Healthcare has a 12 month low of $2.48 and a 12 month high of $6.19. The stock has a market cap of $902.29 million, a price-to-earnings ratio of 231.25 and a beta of 1.98. The firm's 50 day simple moving average is $5.16 and its two-hundred day simple moving average is $4.87.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the sale, the insider directly owned 28,890,756 shares in the company, valued at $150,231,931.20. This trade represents a 2.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Paul R. Vigano sold 750,000 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the sale, the insider owned 28,890,756 shares in the company, valued at approximately $150,231,931.20. This represents a 2.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,115,345 shares of company stock worth $37,838,057 in the last 90 days. Insiders own 7.80% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. First Eagle Investment Management LLC bought a new stake in Aveanna Healthcare during the 4th quarter worth about $1,992,000. Nuveen LLC bought a new position in shares of Aveanna Healthcare in the 1st quarter valued at about $1,692,000. Millennium Management LLC grew its position in shares of Aveanna Healthcare by 105.0% during the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after buying an additional 205,023 shares during the period. Jacobs Levy Equity Management Inc. grew its position in shares of Aveanna Healthcare by 50.1% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after buying an additional 177,856 shares during the period. Finally, Mackenzie Financial Corp raised its stake in shares of Aveanna Healthcare by 145.9% during the first quarter. Mackenzie Financial Corp now owns 263,662 shares of the company's stock worth $1,429,000 after buying an additional 156,439 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.